These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 6773290)

  • 21. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of menstruation with bromocriptine.
    Hahn L
    Am J Obstet Gynecol; 1978 Jan; 130(1):112-3. PubMed ID: 619640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligomenorrhea associated with galactorrhea.
    van Campenhout J; Papas S; Blanchet P; Wyman H; Somma M
    Am J Obstet Gynecol; 1977 Apr; 127(7):723-8. PubMed ID: 322489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperprolactinemia and hypogonadism in the human female.
    Rolland R; Corbey RS
    Eur J Obstet Gynecol Reprod Biol; 1977; 7(5):337-48. PubMed ID: 400856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
    de Bernal M; de Villamizar M
    Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hyperprolactinemic luteal insufficiency with bromocriptine.
    Andersen AN; Larsen JF; Eskildsen PC; Knoth M; Micic S; Svenstrup B; Nielsen J
    Acta Obstet Gynecol Scand; 1979; 58(4):379-83. PubMed ID: 525272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Yellow body function in bromocryptine induced early pregnancy in patients with hyperprolactinemia (author's transl)].
    Smiljanić N; Ciglar S; Podobnik M
    Jugosl Ginekol Opstet; 1981; 21(3-4):65-9. PubMed ID: 6803072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
    Seppälä M; Unnérus HA; Hirvonen E; Ranta T
    J Clin Endocrinol Metab; 1976 Aug; 43(2):474-7. PubMed ID: 950375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotropin, prolactin, and steroid hormone levels after discontinuation of oral contraceptives.
    Klein TA; Mishell DR
    Am J Obstet Gynecol; 1977 Mar; 127(6):585-9. PubMed ID: 842583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea.
    Jeppsson S; Johansson ED; Ljungberg O; Sjöberg NO
    Acta Obstet Gynecol Scand; 1977; 56(1):43-8. PubMed ID: 842303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The recovery of ovarian function during breast-feeding.
    Shaaban MM; Sayed GH; Ghaneimah SA
    J Steroid Biochem; 1987; 27(4-6):1043-52. PubMed ID: 3121930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    March CM; Kletzky OA; Davajan V
    Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
    Spona J; Ulm R; Bieglmayer C; Husslein P
    Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal changes induced by bromocriptine (CB-154) at the early stage of treatment.
    Strauch G; Valcke JC; Mahoudeau JA; Bricaire H
    J Clin Endocrinol Metab; 1977 Mar; 44(3):588-90. PubMed ID: 576425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of hyperprolactinemic amenorrhea by intermittent administration of bromocryptine (CB 154).
    Polatti E; Bolis PF; Ravagni-Probizer MF; Baruffini A; Cavalleri A
    Am J Obstet Gynecol; 1978 Aug; 131(7):792-6. PubMed ID: 567429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.